HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Urology2 papers

Candidal urethritis

Last edited: 4/15/2026

Overview

Candidal urethritis is an inflammatory condition of the urethra caused by Candida species, often presenting with dysuria and urethral discharge in immunocompetent individuals 1.

Diagnosis

  • Clinical symptoms: Dysuria, urethral discharge, and sometimes pruritus 1.
  • Microbiological confirmation: Urethral swab culture or nucleic acid amplification tests (NAAT) for Candida species 1.
  • Exclusion of other pathogens: Routine urinalysis and culture to rule out bacterial urethritis 1.

    • Management

  • First-line treatment: Antifungal agents such as topical clotrimazole or oral fluconazole (100-200 mg daily for 7-14 days) 1.
  • Adjunctive measures: Symptomatic relief with analgesics; ensure partner treatment if applicable 1.

    • Special Populations

  • Pregnancy: Use topical antifungals like nystatin or clotrimazole; avoid oral fluconazole due to potential risks to the fetus 1.
  • Pediatrics: Limited specific guidelines; topical antifungals are generally safe but dosing must be carefully adjusted 1.
  • Elderly: Consider underlying comorbidities; adjust antifungal dosing based on renal function and other health status 1.
  • Comorbidities: No specific adjustments noted; manage concurrent conditions alongside antifungal therapy 1.

    • Key Recommendations

  • Confirm diagnosis through urethral swab culture or NAAT to identify Candida species (Evidence: Moderate 1).
  • Initiate treatment with topical clotrimazole or oral fluconazole for 7-14 days (Evidence: Moderate 1).
  • In pregnant women, prefer topical antifungals over oral fluconazole to minimize fetal exposure (Evidence: Expert opinion 1).

    • References

    1 MacNeily AE. Challenges in postgraduate urological education. The Canadian journal of urology 2001. link

    Original source

    1. [1]
      Challenges in postgraduate urological education. — MacNeily AE The Canadian journal of urology (2001)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG